Table 1 Statin prescription according to demographics, prestroke disability and risk factors/comorbidities
|  | All (12750) | Statin + (5392, 42%) | p-value (χ2) | |
|---|---|---|---|---|
Gender, n (%) | Male: 6779 (53%) | Male | Female | p < 0.0001 |
3107 (46%) | 2285 (38%) | |||
Age, n (%) | Age <80: 8889 (70%) | Age < 80 | Age ≥80 | p < 0.0001 |
4251 (48%) | 1141 (30%) | |||
Prestroke mRS, n§ (%) | mRS 0–1: 5719 (80%) | mRS 0-1 | mRS 2-5 | p < 0.0001 |
mRS 2–5: 1469 (20%) | 2649 (46%) | 468 (32%) | ||
Risk factors, n (%) | Â | Rf present | Rf absent | Â |
Previous TIA/stroke | 2931 (23%) | 1271 (43%) | 4121 (42%) | p = 0.18 |
Arterial hypertension | 8166 (64%) | 3628 (44%) | 1764 (38%) | p < 0.0001 |
Diabetes mellitus | 2619 (21%) | 1284 (49%) | 4108 (41%) | p < 0.0001 |
Myocardial infarction | 1407 (11%) | 832 (59%) | 4560 (40%) | p < 0.0001 |
Hypercholesterolemia | 2366 (19%) | 1686 (71%) | 3706 (36%) | p < 0.0001 |
Coronary artery disease | 999 (8%) | 546 (55%) | 4846 (41%) | p < 0.0001 |
Peripheral artheriopathy | 894 (7%) | 462 (52%) | 4930 (42%) | p < 0.0001 |
Atrial fibrillation | 2150 (17%) | 720 (34%) | 4672 (44%) | p < 0.0001 |
Smoking | 1804 (14%) | 906 (51%) | 4486 (41%) | p < 0.0001 |
Heart failure | 460 (4%) | 190 (41%) | 5202 (42%) | p = 0.66 |
Cognitive impairment | 967 (8%) | 284 (29%) | 5108 (43%) | p < 0.0001 |
Valvular prosthesis | 313 (2%) | 137 (44%) | 5255 (42%) | p = 0.59 |